Analysts at Bank of America have repeated their ‘Underperform’ rating on exercise equipment company Peloton Interactive Inc (NASDAQ:PTON) as they wait for subscriber growth to inflect, despite it reporting a quarterly earnings beat.
Peloton shares surged on Thursday after the company, known primarily for its stationary exercise bikes, reported fiscal fourth quarter earnings above estimates.
Uber Technologies Inc (NYSE:UBER, ETR:UT8)'s new partnership with Cruise to bring its autonomous vehicles to the ride-share platform has reinforced the company’s role as a demand aggregator, analysts at Bank of America believe.
Uber and Cruise, majority-owned by General Motors Company (NYSE:GM), announced on Thursday that it plans to launch the multi-year partnership next year with an unspecified number of Chevy Bolt-based autonomous vehicles (AVs).
Analysts at Noble Capital Markets have repeated their ‘Market Perform’ rating on MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) after the company received registration approval for its biofertility product TerraSante in Arizona.
The approval allows MustGrow to commence TerraSante sales in the state, which produced $3 billion in total agricultural crop products in 2022.
Rolls-Royce Holdings PLC (LSE:RR.) has had its credit rating lifted by agency S&P Global after reporting a jump in margins over the first half of the year.
S&P lifted Rolls-Royce’s rating from BBB/A-3 to BBB/A-2, noting better margins had led to improving expectations for profitability over the coming years.
Melrose Industries PLC (LSE:MRO, OTC:MLSPF) fell over 6% on Friday and dragged down defence peers after facing a double downgrade from UBS analysts.
The FTSE 100-listed defence firm’s rating was slashed from a ‘buy’ to a ‘sell’ by UBS, while Melrose’s share price target was wound down from 770p to 400p.
Is BenevolentAI (OTC:BAIVF) “rebooting pharma in the AI era”?
Quite possibly, according to Deutsche Bank, which recently launched coverage on the London-headquartered company.